USES OF RECOMBINANT YEAST-DERIVED SERUM ALBUMIN
    2.
    发明申请
    USES OF RECOMBINANT YEAST-DERIVED SERUM ALBUMIN 审中-公开
    重组酵母来源的血清白蛋白的用途

    公开(公告)号:WO2018065491A1

    公开(公告)日:2018-04-12

    申请号:PCT/EP2017/075257

    申请日:2017-10-04

    申请人: ALBUMEDIX A/S

    IPC分类号: A01N1/02

    摘要: The invention relates to a methods and uses for the preservation of stem cells, by a method comprising the steps of combining the stem cells with a cryopreservation medium to produce a mixture, and freezing the mixture to produce a frozen stem cell product, optionally, wherein the method further comprises the steps of thawing the frozen stem cell product, transferring the thawed cells to a storage medium, and storing stem cells in the storage medium,wherein the cryopreservation medium and/or the storage medium comprises a recombinant yeast-derived serum albumin preparation, more preferably wherein the recombinant yeast-derived serum albumin preparation is present in the cryopreservation medium and is also present in the storage medium. The invention also relates to methods and uses for the preservation of stem cells, by a method comprising storing stem cells in a storage medium, wherein the stem cells have been frozen in a cryopreservation medium, thawed, and then transferred to the storage medium prior to storage; and wherein the cryopreservation medium and/or the storage medium comprises a recombinant yeast-derived serum albumin preparation, more preferably wherein the recombinant yeast-derived serum albumin preparation is present in the cryopreservation medium and is also present in the storage medium.

    摘要翻译: 本发明涉及用于保存干细胞的方法和用途,其通过包括以下步骤的方法来进行:将干细胞与冷冻保存介质组合以产生混合物,并将混合物冷冻以产生 冷冻干细胞产物,任选地,其中所述方法进一步包括融化所述冷冻干细胞产物,将所述融化细胞转移到存储介质并且将干细胞存储在所述存储介质中的步骤,其中所述冷冻保存介质和/或所述存储介质 包含重组酵母来源的血清白蛋白制剂,更优选其中所述重组酵母来源的血清白蛋白制剂存在于所述冷冻保存介质中并且也存在于所述存储介质中。 本发明还涉及通过包括将干细胞存储在存储介质中的方法和用于保存干细胞的方法和用途,其中干细胞已经在冷冻保存介质中冷冻,解冻,然后在存储介质之前转移到存储介质 存储; 并且其中所述冷冻保存介质和/或所述存储介质包含重组酵母来源的血清白蛋白制剂,更优选其中所述重组酵母来源的血清白蛋白制剂存在于所述冷冻保存介质中并且也存在于所述存储介质中。 >

    IDENTIFICATION AND TREATMENT OF TUMORS CHARACTERIZED BY AN OVEREXPRESSION OF THE NEONATAL FC RECEPTOR
    4.
    发明申请
    IDENTIFICATION AND TREATMENT OF TUMORS CHARACTERIZED BY AN OVEREXPRESSION OF THE NEONATAL FC RECEPTOR 审中-公开
    新生儿FC受体表达过度表达的肿瘤的鉴定和治疗

    公开(公告)号:WO2018082758A1

    公开(公告)日:2018-05-11

    申请号:PCT/DK2017/050363

    申请日:2017-11-03

    摘要: In a first aspect, the invention relates to the identification of cancer types over- expressing the FcRn receptor. In a second aspect, the invention relates to the treatment of said cancer types.In further aspects,the invention relates to identification of subtypes of inflammatory diseases and treatments thereof.In an additional aspect, the invention relates to in vivo imaging of cancers over- expressing the FcRn receptor.

    摘要翻译: 在第一方面,本发明涉及鉴定过表达FcRn受体的癌症类型。 第二方面,本发明涉及所述癌症类型的治疗。在另外的方面,本发明涉及鉴定炎性疾病的亚型及其治疗。在另外的方面,本发明涉及癌症过表达的体内成像, 表达FcRn受体。

    ALBUMIN VARIANTS AND CONJUGATES
    5.
    发明申请
    ALBUMIN VARIANTS AND CONJUGATES 审中-公开
    ALBUMIN变体和并存

    公开(公告)号:WO2017029407A1

    公开(公告)日:2017-02-23

    申请号:PCT/EP2016/069748

    申请日:2016-08-19

    申请人: ALBUMEDIX A/S

    IPC分类号: C07K14/765

    CPC分类号: C07K14/765

    摘要: The present invention relates to conjugation-competent albumins and albumin-related polypeptides, and their conjugates with at least one moiety, and to polynucleotides encoding them.

    摘要翻译: 本发明涉及具有共轭感的白蛋白和白蛋白相关多肽及其与至少一个部分的缀合物,以及编码它们的多核苷酸。